Publicaciones en colaboración con investigadores/as de Institució Catalana de Recerca i Estudis Avançats (10)

2024

  1. Integrative single-cell expression and functional studies unravels a sensitization to cytarabine-based chemotherapy through HIF pathway inhibition in AML leukemia stem cells

    HemaSphere, Vol. 8, Núm. 2

2022

  1. Robust in Vitro and in Vivo Immunosuppressive and Anti-inflammatory Properties of Inducible Caspase-9-mediated Apoptotic Mesenchymal Stromal/Stem Cell

    Stem Cells Translational Medicine, Vol. 11, Núm. 1, pp. 88-96

  2. The Multi-Kinase Inhibitor EC-70124 Is a Promising Candidate for the Treatment of FLT3-ITD-Positive Acute Myeloid Leukemia

    Cancers, Vol. 14, Núm. 6

2021

  1. Engraftment characterization of risk-stratified AML in NSGS mice

    Blood Advances, Vol. 5, Núm. 23, pp. 4842-4854

2020

  1. 41BB-based and CD28-based CD123-redirected T-cells ablate human normal hematopoiesis in vivo

    Journal for immunotherapy of cancer, Vol. 8, Núm. 1

2019

  1. NG2 antigen is a therapeutic target for MLL-rearranged B-cell acute lymphoblastic leukemia

    Leukemia, Vol. 33, Núm. 7, pp. 1557-1569

2018

  1. Detection of inflammatory monocytes but not mesenchymal stem/stromal cells in peripheral blood of patients with myelofibrosis

    British Journal of Haematology

2017

  1. Proinflammatory signals are insufficient to drive definitive hematopoietic specification of human HSCs in vitro

    Experimental Hematology, Vol. 45, pp. 85-93.e2

  2. Therapeutic effect of the immunomodulatory drug lenalidomide, but not pomalidomide, in experimental models of rheumatoid arthritis and inflammatory bowel disease

    Experimental & molecular medicine, Vol. 49, Núm. 2, pp. e290

2014

  1. Genomics of ecological adaptation in cactophilic Drosophila

    Genome Biology and Evolution, Vol. 7, Núm. 1, pp. 349-366